The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Campaigns & Insights
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Issues / 2026 / September / A Dual Approach for Pterygium Removal
Anterior Segment Cornea Opinions

A Dual Approach for Pterygium Removal

Optimizing pterygium removal with conjunctival autograft and amniotic membrane graft

By Himani Goyal 9/7/2026 3 min read

Share

  • Full Article
  • Summary
  • Takeaways
  • Report
  • Scorecard
  • Quiz
  • Poll
  • Topic Commentary
3 Topic Commentaries

A Dual Approach for Pterygium Removal

A Dual Approach for Pterygium Removal

  • Matt (Matthew S.) Ward
    Matt (Matthew S.) Ward, MD

    Cornea and External Disease

    •

    University of Iowa Carver College of Medicine, Department of Ophthalmology & Visual Sciences

    Pterygium surgery with conjunctival autograft remains the gold standard for reducing recurrence after its initial description in 1985 (Kenyon KR, Wagoner MD Hettinger ME. Conjunctival autograft transplantation for advanced and recurrent pterygium . Ophthalmology1985; 92, 1461-1470). Recurrence rates are consistently reported in the 5-10% range. The technique demonstrated in this video makes use of Tisseel fibrin glue to anchor the graft in the bed.

    Source
  • William Charles Caccamise, Sr.
    William Charles Caccamise, Sr., MD

    Ophthalmology (Cornea/Anterior Segment)

    •

    University of Rochester School of Medicine and Dentistry

    At the time of this posting, the technique of John A. Hovanesian, MD would seem to offer encouraging results. He employs a thin autograft of superior limbic conjunctival-corneal tissue containing stem cells. The autograft is glued to the bare sclera at the site of the dissected pterygium. The glue is a fibrin glue - Tisseel.This fibrin glue obviates the use of sutures in placing the autograft.

    Source
  • Mary P. Coday
    Mary P. Coday, MD

    Ophthalmology

    •

    Massachusetts Eye and Ear Infirmary, Harvard Medical School

    The removal may take place in a procedure room or operating room setting. The pterygium is carefully dissected away. In ORDER to prevent regrowth of the pterygium, your ophthalmologist may remove some of the surface tissue of the same eye (conjunctiva) and suture it INTO the bed of the excised pterygium. Alternatively, an antimetabolite such as mitomycin may be applied to the site. Postoperatively, your ophthalmologist may recommend some steroid eye drops for several weeks to decrease the inflammation and prevent regrowth of the pterygium.

    Source

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Related Content

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: